DK609184A - 5-pyrimidincarboxamider og thiocarboxamider samt behandling af leukaemi og tumorer dermed - Google Patents

5-pyrimidincarboxamider og thiocarboxamider samt behandling af leukaemi og tumorer dermed Download PDF

Info

Publication number
DK609184A
DK609184A DK609184A DK609184A DK609184A DK 609184 A DK609184 A DK 609184A DK 609184 A DK609184 A DK 609184A DK 609184 A DK609184 A DK 609184A DK 609184 A DK609184 A DK 609184A
Authority
DK
Denmark
Prior art keywords
thiocarboxamides
leukaemia
tumors
treatment
pyrimidine carboxamides
Prior art date
Application number
DK609184A
Other languages
English (en)
Other versions
DK609184D0 (da
DK164055B (da
DK164055C (da
Inventor
Arthur D Brewer
John A Minatelli
Original Assignee
Uniroyal Inc
Uniroyal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Inc, Uniroyal Ltd filed Critical Uniroyal Inc
Publication of DK609184D0 publication Critical patent/DK609184D0/da
Publication of DK609184A publication Critical patent/DK609184A/da
Publication of DK164055B publication Critical patent/DK164055B/da
Application granted granted Critical
Publication of DK164055C publication Critical patent/DK164055C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK609184A 1983-12-19 1984-12-18 2-thioxo-5-pyrimidincarboxamider, farmaceutisk middel indeholdende disse til at inducere regression af leukaemi og haemning af vaekst af tumorer og fremgangsmaader til deres fremstilling DK164055C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US56269383 1983-12-19
US66520184A 1984-10-26 1984-10-26
US66526784A 1984-10-26 1984-10-26
US66526784 1984-10-26
US66520184 1984-10-26

Publications (4)

Publication Number Publication Date
DK609184D0 DK609184D0 (da) 1984-12-18
DK609184A true DK609184A (da) 1985-06-20
DK164055B DK164055B (da) 1992-05-04
DK164055C DK164055C (da) 1992-09-28

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
DK609184A DK164055C (da) 1983-12-19 1984-12-18 2-thioxo-5-pyrimidincarboxamider, farmaceutisk middel indeholdende disse til at inducere regression af leukaemi og haemning af vaekst af tumorer og fremgangsmaader til deres fremstilling

Country Status (19)

Country Link
US (1) US4634707A (da)
JP (1) JPH0660164B2 (da)
AT (1) AT394194B (da)
AU (1) AU580746B2 (da)
BE (1) BE901301A (da)
CH (1) CH671225A5 (da)
DE (1) DE3446371A1 (da)
DK (1) DK164055C (da)
ES (1) ES8606296A1 (da)
FR (1) FR2557108B1 (da)
GB (1) GB2152047B (da)
GR (1) GR82494B (da)
IE (1) IE57675B1 (da)
IL (1) IL73840A (da)
IT (1) IT1213257B (da)
LU (1) LU85696A1 (da)
NL (1) NL8403856A (da)
NZ (2) NZ210599A (da)
SE (1) SE469171B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
PH24423A (en) * 1985-02-15 1990-06-25 Ciba Geigy Ag 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
WO1991013623A1 (en) * 1990-03-09 1991-09-19 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
AU2001257230B2 (en) 2000-04-24 2006-09-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
US10093631B2 (en) * 2014-02-14 2018-10-09 Acquist Llc Bifunctional compounds and use for reducing uric acid levels
EP3247704A4 (en) * 2015-01-22 2018-10-03 Acquist LLC Bifunctional compounds and use for reducing uric acid levels
TWI772309B (zh) * 2016-06-30 2022-08-01 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(二)
WO2018009615A1 (en) 2016-07-06 2018-01-11 Acquist Llc Compounds and their use for reducing uric acid levels
IT201700028709A1 (it) * 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
DE2962834D1 (en) * 1978-10-30 1982-07-01 Fujisawa Pharmaceutical Co 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
GB2126582B (en) * 1982-08-26 1986-03-05 Ciba Geigy Ag Phenyl carbamoyl barbituric acid anthelmintics
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
ZA849819B (en) * 1983-12-19 1985-07-31 Uniroyal Inc 5-pyrimidinecarboxamides and thiocarboxamides and treatment of leukemia and tumors therewith
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
JPS641445A (en) 1987-06-22 1989-01-05 Toshiba Corp Manufacture of stator coil

Also Published As

Publication number Publication date
IL73840A0 (en) 1985-03-31
BE901301A (fr) 1985-06-18
IE843237L (en) 1985-06-19
GB2152047B (en) 1988-04-27
JPS62174058A (ja) 1987-07-30
DK609184D0 (da) 1984-12-18
SE8406450L (sv) 1985-06-20
GB2152047A (en) 1985-07-31
IT8424104A0 (it) 1984-12-18
DK164055B (da) 1992-05-04
GB8432112D0 (en) 1985-01-30
ATA402684A (de) 1991-08-15
FR2557108A1 (fr) 1985-06-28
DE3446371A1 (de) 1985-06-27
IT1213257B (it) 1989-12-14
LU85696A1 (fr) 1985-09-12
JPH0660164B2 (ja) 1994-08-10
CH671225A5 (da) 1989-08-15
AU3690884A (en) 1985-07-04
NL8403856A (nl) 1985-07-16
US4634707A (en) 1987-01-06
IE57675B1 (en) 1993-02-24
SE469171B (sv) 1993-05-24
DE3446371C2 (da) 1990-08-16
GR82494B (en) 1985-04-19
IL73840A (en) 1988-11-15
AT394194B (de) 1992-02-10
ES8606296A1 (es) 1986-04-16
ES538829A0 (es) 1986-04-16
FR2557108B1 (fr) 1988-11-18
AU580746B2 (en) 1989-02-02
NZ220399A (en) 1987-09-30
DK164055C (da) 1992-09-28
SE8406450D0 (sv) 1984-12-18
NZ210599A (en) 1987-09-30

Similar Documents

Publication Publication Date Title
DK528683D0 (da) Elektrookulografisk system med databehandling og tilbagekobling af stimuli
DK377085D0 (da) Diagnostikum og kontrastmiddel
DK0445255T3 (da) Behandling af tilstande og sygdom
IT8423534A1 (it) Dispositivo per ricevere e trattare sangue
DK159984C (da) Proces- eller behandlingsapparat
DK609184A (da) 5-pyrimidincarboxamider og thiocarboxamider samt behandling af leukaemi og tumorer dermed
NO901141D0 (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
IT8349562A0 (it) Apparecchio e procedimento di cardatura
DK80184A (da) Fremgangsmaade og kredsloeb til behandling af impulser
DK454683D0 (da) Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
IT8448893A1 (it) Procedimento ed apparecchio di trebbiatura
DK182986D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi og tumorer dermed
DK117784D0 (da) Bejdseoploesning til bejdsning af metaloverflader og anvendelse af denne oploesning
IT1198843B (it) Pannello-parete e suoi componenti
DK154283D0 (da) Produkter og metoder til behandling af cancer
IT1189033B (it) Apparecchio ortopedico e procedimento di applicazione
NO871119D0 (no) Fremgangsmaate og anordning for cracking av restoljer.
DK51683D0 (da) Traekindretning til trawlere af typerne sidefangere og haektrawlere
DE3475192D1 (de) Pyrrolizidinones and indolizidones
DK626784D0 (da) Fremgangsmaade og rensning af alkylerede antraquinoner
DK394488A (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
DK394388D0 (da) 5-pyrimidincarboxamider og behandling af leukaemi dermed
KR850002038U (ko) 시계와 시각설정 장치
ES524607A0 (es) Dispositivo de embuticion y fijado de bisagras y bases.
IT1170707B (it) Procedimento per preparare 2-ammino 5-nitro-benzofenone e suoi 2-alogeno-derivati

Legal Events

Date Code Title Description
PBP Patent lapsed